Protein catabolism in chronic uremia: Is it due to malnutrition?

Archivum Immunologiae et Therapiae Experimentalis

Volumn 52, Issue 5, 2004, Pages 326-331

  Ahuja, Tejinder S ^a,b   Mitch, William E ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Dialysis; Malnutrition; Muscle atrophy

Indexed keywords

ALBUMIN; PLASMA PROTEIN;

ANTHROPOMETRIC PARAMETERS; DIAGNOSTIC ERROR; DISEASE CLASSIFICATION; HEMODIALYSIS PATIENT; HUMAN; MALNUTRITION; MUSCLE ATROPHY; MUSCLE MASS; NUTRITIONAL STATUS; PREVALENCE; PROTEIN CALORIE MALNUTRITION; PROTEIN DEGRADATION; REVIEW; UREMIA;

CHRONIC DISEASE; HUMANS; MALNUTRITION; MUSCULAR ATROPHY; PROTEINS; UREMIA;

EID: 10344240412     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Abrahmsen B., Hansen T. B., Hogsberg I. M., Pedersen F. B. and Beck-Nielsen H. (1996): Impact of hemodialysis on dual-X-ray absorptiometry, bioelectrical impedance measurements, and anthropometry. Am. J. Clin. Nutr., 63, 80-86.
2. Allman M. A., Allen B. J., Stewart P. M., Blagojevic N., Tiller D. J., Gaskin K. J. and Truswell A.S.(1990): Body protein of patients undergoing haemodialysis. Eur. J. Clin. Nutr., 44, 123-131.
3. Anderstam B., Mamoun A. H., Bergstrom J. and Sodersten P. (1996): Middle-sized molecule fractions isolated from uremic ultrafiltrate and normal urine inhibits ingestive behavior in the rat. J. Am. Soc. Nephrol., 7, 2453-2460.
4. Aparicio M., Chauveau P., dePrecigout V., Bouchet J. L., Lasseur C. and Combe C. (2000): Nutrition and outcome on renal replacement therapy of patients with chronic renal failure treated by a supplemented very low protein diet. J. Am. Soc. Nephrol., 11, 719-727.
5. Bailey J. L., Wang X., England B. K., Price S. R., Ding X. and Mitch W. E. (1996): The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent, ubiquitin-proteasome pathway. J. Clin. Invest., 97, 1447-1453.
6. Baker J. P., Detsky A. S., Wesson D. E., Wolman S. L., Stewart S., Whitewell J., Langer B. and Jeejeebhoy K. N. (1982): Nutritional assessment: a comparison of clinical judgement and objective measurements. N. Engl. J. Med., 306, 969-972.
7. Ballmer P. E., McNurlan M. A., Hulter H. N., Anderson S. E., Garlick P. J. and Krapf R. (1995): Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. J. Clin. Invest., 95, 39-45.
8. Borah M. F., Schoenfeld P. Y., Gotch F. A., Sargent J. A., Wolfson M. and Humphreys M. H. (1978): Nitrogen balance during intermittent dialysis therapy of uremia. Kidney Int., 14, 491-500.
9. Borovnicar D. J., Wong K. C., Kerr P. G., Stroud D. B., Xiong D. W., Strauss B. J. and Atkins R. C. (1996): Total body protein status assessed by different estimates of fat-free mass in adult peritoneal dialysis patients. Eur. J. Clin. Nutr., 50, 607-616.
10. Chertow G. M., Ackert K., Lew N. L., Lazarus J. M. and Lowrie E. G. (2000): Prealbumin is as important as albumin in the nutritional assessment of hemodialysis patients. Kidney Int., 58, 2512-2517.
11. Cooper B. A., Barlett L. H., Aslani A., Allen B. J., Ibels L. S. and Pollock C. A. (2002): Validity of subjective global assessment as a nutritional marker in end-stage renal disease. Am. J. Kidney Dis., 40, 126-132.
12. DeFronzo R. A., Tobin J. D., Rowe J. W. and Andres R. (1978): Glucose intolerance in uremia. J. Clin. Invest., 62, 425-430.
13. Detsky A. S., McLaughlin J. R., Baker J. P., Johnston N., Whittaker S., Mendelson R. A. and Jeejeebhoy K. N. (1987): What is subjective global assessment of nutritional status? J. Parenter. Enteral. Nutr., 11, 8-13.
14. Du J., Mitch W. E., Wang X. and Price S. R. (2000): Glucocorticoids induce proteasome C3 subunit expression in L6 muscle cells by opposing the suppression of its transcription by NF-κB. J. Biol. Chem., 275, 19661-19666.
15. Du J., Wang X., Miereles C., Bailey J. L., Debigare R., Zheng B., Price S. R. and Mitch W. E. (2004): Activation of caspase 3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions, J. Clin. Invest., 113, 115-123.
16. England B. K., Greiber S., Mitch W. E., Bowers B. A., Herring W. J., McKean M., Ebb R. G., Price R. and Danner D. J. (1995): Rat muscle branched-chain ketoacid dehydrogenase activity and mRNAs increase with extracellular acidemia. Am. J. Physiol., 268, C1395-C1400.
17. Enia G., Sicuso C., Alati G. and Zoccali C. (1993): Subjective global assessment of nutrition in dialysis patients. Nephrol. Dial. Transplant., 8, 1094-1098.
18. Ford J., Phillips M. E., Toye F. E., Luck V. A. and de Wardener H. E. (1969): Nitrogen balance in patients with chronic renal failure on diets containing varying quantities of protein. Br. Med. J., 1, 735-740.
19. Goldberg A. L., Kettlehut I. C., Furuno K., Fagan J. M. and Baracos V. (1988): Activation of protein breakdown and prostaglandin E2 production in rat skeletal muscle in fever is signaled by a macrophage product distinct from interleukin 1 or other known monokines. J. Clin. Invest., 81, 1378-1383.
20. Goodman M. N. (1991): Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am. J. Physiol., 260, E727-E730.
21. Goodship, T. H. J., Mitch W. E., Hoerr R. A., Wagner D. A., Steinman T. I. and Young V. R. (1990): Adaptation to low-protein diets in renal failure: leucine turnover and nitrogen balance. J. Am. Soc. Nephrol., 1, 66-75.
22. Graham K. A., Reaich D., Channon S. M., Downie S., Gilmour E., Passlick-Deetjen J. and Goodship T. H. (1996): Correction of acidosis in CAPD decreases whole body protein degradation. Kidney Int., 49, 1396-1400.
23. Graham K. A., Reaich D., Channon S. M., Downie S. and Goodship T. H. J. (1997): Correction of acidosis in hemodialysis decreases whole-body protein degradation. J. Am. Soc. Nephrol., 8, 632-637.
24. Guiterrez A., Alvestrand A., Wahren J. and Bergstrom J. (1990): Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney Int., 38, 487-494.
25. Gutierrez A., Bergstrom J. and Alvestrand A. (1994): Hemodialysis- associated protein catabolism with and without glucose in the dialysis fluid. Kidney Int., 46, 814-822.
26. Hara Y., May R. C., Kelly R. A. and Mitch W. E. (1987): Acidosis, not azotemia, stimulates branched-chain amino acid catabolism in uremic rats. Kidney Int., 32, 808-814.
27. Holland D. C., Meers C., Lawlor M.E. and Lam M. (2001): Serial prealbumin as predictors of outcomes in a retrospective cohort of peritoneal and hemodialysis patients. J. Ren. Nutr., 10, 129-138.
28. Ikizler T. A., Pupim L. B., Brouillette J. R., Levenhagen D. K., Farmer K., Hakim R. M. and Flakoll P. J. (2002): Hemodialysis stimulates muscle and whole body protein loss and alters substrate oxidation. Am. J. Physiol., 282, E107-E116.
29. Kalantar-Zadeh K., Ikizler T. A., Block G., Avram M. M. and Kopple J. D. (2003): Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am. J. Kidney Dis., 42, 864-881.
30. Kaysen G. A. (1998): Biological basis of hypoalbuminemia in ESRD. J. Am. Soc. Nephrol., 9, 2368-2376.
31. Kaysen G. A., Dubin J. A., Muller H. G., Mitch W. E. and Levin N. W. (2001): Levels of al acid glycoprotein and ceruloplasmin predict future albumin levels in hemodialysis patients. Kidney Int., 60, 2360-2366.
32. Kaysen G. A., Dubin J. A., Muller H. G., Rosales L., Levin N. W. and Mitch W. E. (2004): Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients. HEMO Study Group NIDDK. Kidney Int., 65, 1408-1415.
33. Kaysen G. A., Stevenson F. T., and Depner T. A. (1997): Determinants of albumin concentration in hemodialysis patients. Am. J. Kidney Dis., 29, 658-668.
34. Keefe A. O. and Daigle N. W. (2002): A new approach to classifying malnutrition in the hemodialysis patient. J. Ren. Nutr., 12, 248-255.
35. Kerr P. G., Strauss B. J. and Atkins R. C. (1996): Assessment of the nutritional state of dialysis patients. Blood Purif., 14, 382-387.
36. Kimmel P. L., Phillips T. M., Simmens S. J., Peterson R. A., Weihs K. L., Alleyne S., Cruz I., Yanovski J. A. and Veis J. H. (1998): Immunologic function and survival in hemodialysis patients. Kidney Int., 54, 236-244.
37. Kopple J. D. and Swendseid M. E. (1974): Nitrogen balance and plasma amino acid levels in uremic patients fed an essential amino acid diet. Am. J. Clin. Nutr., 27, 806-812.
38. Leavey S. F., Strawderman R. L., Jones C. A., Port F. K. and Held P. J. (1998): Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am. J. Kidney Dis., 31, 992-1006.
39. Lim V. S., Bier D. M., Flanigan M. J. and Sum-Ping S. T. (2002): The effect of hemodialysis on protein metabolism: a leucine kinetic study. J. Clin. Invest., 91, 2429-2436.
40. Lowrie E. G., Huang W. H., Lew N. L. and Liu Y. (1994): The relative contribution of measured variables to death risk among hemodialysis patients. In Friedman E. A. (ed.): Death on hemodialysis. Kluwer Academic, Amsterdam, 121-141.
41. ++-activated and ATP-ubiquitin-dependent proteolytic pathways in skeletal muscle from head trauma patients. Proc. Natl. Acad. Sci. USA, 93, 2714-2718.
42. Maroni B. J., Staffeld C., Young V. R., Manatunga A. and Tom K. (1997): Mechanisms permitting nephrotic patients to achieve nitrogen equilibrium with a protein-restricted diet. J. Clin. Invest., 99, 2479-2487.
43. May R. C., Kelly R. A. and Mitch W. E. (1987): Mechanisms for defects in muscle protein metabolism in rats with chronic uremia: the influence of metabolic acidosis. J. Clin. Invest., 79, 1099-1103.
44. Mitch W. E. (2002): Malnutrition a frequent misdiagnosis for hemodialysis patients. J. Clin. Invest., 110, 437-439.
45. Mitch W. E. (2003): Getting beyond cross-sectional studies of abnormal nutritional indexes in dialysis patients. Am. J. Clin. Nutr., 77, 760-761.
46. Mitch W. E., Abras E. and Walser M. (1982): Long term effects of new ketoacid-amino acid supplement in patients with chronic renal failure. Kidney Int., 22, 48-53.
47. Mitch W. E., Bailey J. L., Wang X., Jurkovitz C., Newby D. and Price S. R. (1999): Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting. Am. J. Physiol., 276, C1132-C1138.
48. Mitch W. E. and Goldberg A. L. (1996): Mechanisms of muscle wasting: the role of the ubiquitin-proteasome system. N. Engl. J. Med., 335, 1897-1905.
49. Mitch W. E. and Price S. R. (2001): Transcription factors and muscle cachexia: have we defined a therapeutic target? Lancet, 357, 734-735.
50. Motil K. J., Matthews D. E., Bier D. M., Burke J. F., Munro H. N. and Young V. R. (1981): Whole-body leucine and lysine metabolism: response to dietary protein intake in young men. Am. J. Physiol., 240, E712-E721.
51. Movilli E., Zani R., Carli O., Sangalli L., Pola A., Camerini C., Cancarini G. C., Scolari F., Feller P. and Maiorca R. (1998): Correction of metabolic acidosis increases serum albumin concentration and decreases kinetically evaluated protein intake in hemodialysis patients: a prospective study. Nephrol. Dial. Transpl., 13, 1719-1722.
52. National Kidney Foundation (2000): K/DOQ1 clinical practice guidelines for nutrition in chronic renal failure. Am. J. Kidney Dis., 35 (suppl. 2), S1-S140.
53. Neyra N. R., Hakim R. M., Shy Y. and Ikizler T. A. (2000): Serum transferrin and serum prealbumin are early predictors of serum albumin in chronic hemodialysis patients. J. Ren. Nutr., 10, 184-190.
54. Peocits-Filho R., Lindholm B. and Stenvinkel P. (2002): The malnutrition, inflammation, and atherosclerosis (MIA) syndrome-the heart of the matter. Nephrol. Dial. Transplant., 11, 28-31.
55. Pereira B. J., Shapiro L., King A. J., Falagas M. E., Strom J. A. and Dinarello C. A. (1994): Plasma levels of IL-1β, TNF-α and their specific inhibitors in undialyzed chronic renal failure, CAPD, and hemodialysis patients. Kidney Int., 45, 890-896.
56. Pickering W. P., Price S. R., Bircher G., Marinovic A. C., Mitch W. E. and Walls J. (2002): Nutrition in CAPD: serum bicarbonate and the ubiquitin-proteasome system in muscle. Kidney Int., 61, 1286-1292.
57. Pollock C. A., Ibels L. S., Allen B. J., Ayass W., Caterson R. J., Waugh D. A., Macadam C., Pennock Y. and Mahony J. F. (1995): Total body nitrogen as a prognostic marker in maintenance dialysis. J. Am. Soc. Nephrol., 6, 82-88.
58. Price S. R., Bailey J. L., Wang X., Jurkovitz C., England B. K., Ding X., Phillips L. S. and Mitch W. E. (1996): Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome pathway by a mechanism including gene transcription. J. Clin. Invest., 98, 1703-1708.
59. Price S. R., England B. K., Bailey J. L., Van Vreede K. and Mitch W. E. (1994): Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNAs in rat muscle. Am. J. Physiol., 267, C955-C960.
60. Price S. R. and Mitch W. E. (1994): Metabolic acidosis and uremic toxicity: protein and amino acid metabolism. Semin. Nephrol., 14, 232-237.
61. Pupim L. B., Flakoll P. J., Brouillette J. R., Levenhagen D. K., Hakim R. M. and Ikizler T. A. (2002): Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients. J. Clin. Invest., 110, 483-492.
62. Pupim L. B. and Ikizler T. A. (2003): Uremic malnutrition: new insights into an old problem. Semin. Dial., 16, 224-232.
63. Qureshi A. R., Alvestrand A., Danielsson A., Divino-Filho J. C., Gutierrez A., Lindholmv B. and Bergstrom J. (1998): Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int., 53, 773-782.
64. Smith G., Robinson P. H. and Fleck A. (1996): Serum albumin distribution in early treated anorexia nervosa. Nutrition, 12, 677-684.
65. Steinman T. I. (2000): Serum albumin: its significance in patients with ESRD. Semin. Dial., 13, 404-408.
66. Stenvinkel P. and Alvestrand A. (2002): Inflammation in end-stage renal disease: sources, consequences, and therapy. Semin. Dial., 15, 329-337.
67. Stenvinkel P., Heimburger O., Paultre F., Diczfalusy U., Wang T., Berglund L. and Jogestrand T. (1999): Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int., 55, 1899-1911.
68. Tiao G., Fagan J., Roegner V., Lieberman M., Wang J. J., Fischer J. E. and Hasselgren P. O. (1996): Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. J. Clin. Invest., 97, 339-348.
69. Tiao G., Hobler S., Wang J. J., Meyer T. A., Luchette F. A., Fischer J. E. and Hasselgren P. O. (1997): Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. J. Clin. Invest., 99, 163-168.
70. Tom K., Young V. R., Chapman T., Masud T., Akpele L. and Maroni B. J. (1995): Long-term adaptive responses to dietary protein restriction in chronic renal failure. Am. J. Physiol., 268, E668-E677.
71. Walser M. and Hill S. (1999): Can renal replacement be deferred by a supplemented very-low protein diet? J. Am. Soc. Nephrol., 10, 110-116.
72. Wing S. S. and Goldberg A. L. (1993): Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. Am. J. Physiol., 264, E668-E676.
73. Zimmerman J., Herrlinger S., Pruy A., Metzger T. and Wanner C. (1999): Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int., 55, 648-658.